Bank of America
ANAC

Bank of America’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bank of America’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-172,011
Closed -$9.19M – 7807
2016
Q1 		$9.19M Buy
172,011
+21,833
+15% +$1.61M ﹤0.01% 2215
2015
Q4 		$17M Buy
150,178
+41,018
+38% +$4.52M ﹤0.01% 1790
2015
Q3 		$12.8M Buy
109,160
+95,313
+688% +$12.4M ﹤0.01% 1984
2015
Q2 		$1.07M Buy
13,847
+13,160
+1,916% +$863K ﹤0.01% 4053
2015
Q1 		$39K Sell
687
-2,199
-76% -$93.4K ﹤0.01% 5780
2014
Q4 		$93K Sell
2,886
-2,625
-48% -$78.8K ﹤0.01% 5946
2014
Q3 		$135K Sell
5,511
-9,393
-63% -$191K ﹤0.01% 5761
2014
Q2 		$265K Buy
14,904
+7,191
+93% +$116K ﹤0.01% 5281
2014
Q1 		$154K Sell
7,713
-4,981
-39% -$96.6K ﹤0.01% 5651
2013
Q4 		$213K Buy
12,694
+8,278
+187% +$115K ﹤0.01% 5532
2013
Q3 		$47K Sell
4,416
-17,073
-79% -$149K ﹤0.01% 6470
2013
Q2 		$120K Buy
+21,489
New +$130K ﹤0.01% 6060

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Bank of America's ANAC Position: Q2 2016 in Review

Bank of America sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 172,011 shares — an estimated $9.19M sold.

Bank of America first reported a position in ANAC in Q2 2013 and held it in 12 quarters. The position peaked at $17M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Bank of America reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Bank of America sold 172,011 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $9.19M.
  • Bank of America first reported a position in ANACOR PHARMACEUTICALS INC COM in Q2 2013 and held it in 12 quarters.
  • Bank of America's ANACOR PHARMACEUTICALS INC COM position peaked at $17M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Bank of America's 13F filing for Q2 2016, filed 15 Aug 2016.